Abstract
Bone is one of the most common metastatic sites among breast cancer (BC) patients. Once bone metastasis is developed, patients’ survival and quality of life will be significantly declined. At present, there are limited therapeutic options for BC patients with bone metastasis. Different nanotechnology-based delivery systems have been developed aiming to specifically deliver the therapeutic agents to the bone. The conjugation of targeting agents to nanoparticles can enhance the selective delivery of various payloads to the metastatic bone lesion. The current review highlights promising and emerging advanced nanotechnologies designed for targeted delivery of anticancer therapeutics, contrast agents, photodynamic and photothermal materials to the bone to achieve the goal of treatment, diagnosis, and prevention of BC bone metastasis. A better understanding of various properties of these new therapeutic approaches may open up new landscapes in medicine towards improving the quality of life and overall survival of BC patients who experience bone metastasis.
Funder
National Breast Cancer Foundation
Reference113 articles.
1. Breast cancer
2. Breast Cancerhttps://www.who.int/news-room/fact-sheets/detail/breast-cancer
3. How Common Is Breast Cancer?https://www.cancer.org/cancer/breast-cancer/about/how-common-is-breast-cancer.html
4. Global Trend of Breast Cancer Mortality Rate: A 25-Year Study
5. Repeated observation of breast tumor subtypes in independent gene expression data sets
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献